French quantum computing company Pasqal announced it has surpassed 1,000 atoms in its neutral-atom quantum processor, marking a milestone in scaling quantum hardware. The achievement demonstrates the ability to control and manipulate over a thousand individual atoms, which is a key step toward building larger, more powerful quantum computers.
French quantum computing company Pasqal announced it has surpassed 1,000 atoms in its neutral-atom quantum processor, marking a milestone in scaling quantum hardware. The achievement demonstrates the ability to control and manipulate over a thousand individual atoms, which is a key step toward building larger, more powerful quantum computers.
The article explores recent advances in cancer vaccine development, including personalized mRNA vaccines and combination therapies, and examines whether these new approaches will succeed where previous attempts have failed. It details the scientific challenges involved and the cautious optimism surrounding ongoing clinical trials.
New research suggests creatine, commonly known as a muscle-building supplement, may also boost the immune system's ability to fight cancer. Studies in mice showed creatine helped T-cells become more effective at attacking tumors. The findings could open new avenues for enhancing cancer immunotherapies.
An interview with researcher Cassandra Rauert examines the widespread presence of microplastics in human organs, blood, and breast milk. While particles enter through food, water, and air, the long-term health effects remain unknown, underscoring the need for further research.
A new blood test breakthrough now allows non-invasive assessment of the tumor microenvironment (TME), which is crucial for cancer treatment and outcomes. The TME consists of immune cells, blood vessel cells, fibroblasts, and matrix surrounding cancer cells.
A comparative analysis finds that small-molecule drugs carry significantly more information per atom than biologics, based on Shannon entropy calculations from molecular weight and atom counts. This suggests fundamental structural and data-density differences between the two drug classes, with implications for informatics and drug discovery.